Two patients with advanced multiple myeloma were treated with oral low-dose cyclosporin A, one without other therapy and one in conjunction with chemotherapy to which the patient had been previously unresponsive. Both patients had objective laboratory and clinical responses. In the patient treated with cyclosporin A alone, decreasing serum IL-6 and beta-2-microglobulin levels fell as the clinical response evolved. Cyclosporin A deserves further evaluation in the therapy of multiple myeloma.
|Original language||English (US)|
|Number of pages||4|
|Journal||Leukemia and Lymphoma|
|State||Published - 1994|
- Cyclosporin therapy
ASJC Scopus subject areas
- Cancer Research